CardioTek EP-TRACER Software V1.x and V2.0 The EP-TRACER System is an electrophysiology measurement system used to acquire, filter, digitize, amplify, display, and record signals obtained during electrophysiological studies and related procedures. The system allows the user to monitor, display and record the signals. The system incorporates a stimulator intended to be used for diagnostic cardiac stimulation during electrophysiological testing of the heart.
Publicado el 12 de julio de 2017 · Inicio del retiro: 13 de abril de 2017
Resumen
FDA registra el retiro Z-2657-2017 de dispositivos médicos de Clase II, publicado el 12 de julio de 2017 e iniciado el 13 de abril de 2017. Empresa responsable: CardioTek BV; Estado: Completado; Cantidad reportada: 8 units US; Lote: All EP-Tracer -FSCA-identifier (2017-04-06). La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Completed — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Software bug which allows parameters to be changed unintentionally during use.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- CardioTek BV
- Distribuidor
- Worldwide Distribution: US (nationwide) to states of: CA, IL, OH, and MN; and countries of: Albania, Algeria, Argentina, Bangladesh, Belgium, Bolivia, Brazil, Canada, Chile, Colombia, Costa Rica, Croatia, Cuba, Czech Rep, Denmark, Ecuador, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Guatemala, Honduras, Hungary, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Jordan, Kosovo, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malaysia, Malta, Mexico, Monaco, Morocco, Netherlands, Norway, Pakistan, Palestine, Peru, Philippines, Poland, Portugal, Rep. Dominicana, Romania, Russia, Saudi Arabia, Singapore, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Syria, Trinidad & Tobago, Turkey, United Arab Emirates, United Kingdom, Venezuela and Vietnam.
- Lote
- All EP-Tracer -FSCA-identifier (2017-04-06)
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- Netherlands
Retiros relacionados
- FDADrew Scientific DREW 3-PAC Reagent Kit containing: 5L Diluent, 750 mL Enzymatic Cleaner, and 125 mL Lysing12 de julio de 2017
- FDA3DKNEE(TM) SYSTEM e+, tibial Insert, LEFT Sz 6 / 11mm, REF 391-11-706, QTY 01, The 3DKnee Insert HXL Tibial12 de julio de 2017
- FDABoston Scientific Imager II Angiographic Catheter, a pathway for delivering contrast media to selected sites12 de julio de 2017
- FDANussloch GmbH ASP6025 Tissue Processor12 de julio de 2017
- FDARobin Hood All Purpose Flour 1.8kg retial Pouch 6/1.8kg retial pouches per wholesale case12 de julio de 2017
- FDAMedacta GMK HINGE, Tibial Insert Fixed, SIZE 2, HEIGHT 23 mm, REF 02.09.0223H, STERILE EO12 de julio de 2017
Preguntas sobre este retiro
¿CardioTek EP-TRACER Software V1.x and V2.0 The EP-TRACER System is an electrophysiology measurement system used to acquire, filter, digitize, amplify, display, and record signals obtained during electrophysiological studies and related procedures. The system allows the user to monitor, display and record the signals. The system incorporates a stimulator intended to be used for diagnostic cardiac stimulation during electrophysiological testing of the heart. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2657-2017 el 12 de julio de 2017. Peligro reportado: Software bug which allows parameters to be changed unintentionally during use.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter